Thanks Fouremm. I didn't bother to dig back into it. Also keep in mind that there are several other lead compounds that Resverlogix has identified that are not published and may be superior to RVX-297 and/or RVX-208 for the auto-immune indications. They haven't discussed them recently, but back in fall 2016 at the AGM they listed in a slide RVX-206, RVX-641, RVX-2101 and RVX-2113 as new compounds for autoimmune. That slide didn't list RVX-297. Just because RVX-297 is published doesn't mean that it is their best molecule for auto-immune. Look back at this post for the ping pong of the 297 compound between Resverlogix and Zenith. Most likely both companies have discovered better molecules than 297 and have moved on from 297.

BearDownAZ